• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    3M Reports First-Quarter 2026 Results

    4/21/26 6:30:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care
    Get the next $MMM alert in real time by email
    • Q1 GAAP sales of $6.0 billion, up 1.3%; operating margin of 23.2%, up 230 bps; EPS of $1.23, down 40%, all YoY
      • Adjusted sales of $6.0 billion with organic growth of 1.2% YoY
      • Adjusted operating margin of 23.8%, up 30 bps YoY
      • Adjusted EPS of $2.14, up 14% YoY
    • Q1 operating cash flow of $0.6 billion with adjusted free cash flow of $0.5 billion
    • Reiterates full-year 2026 guidance

    ST. PAUL, Minn., April 21, 2026 /PRNewswire/ -- 3M (NYSE:MMM) today reported first-quarter results.

    "We are executing on 3M's value creation framework to build a stronger company," said William Brown, 3M Chairman and CEO. "Our focus remains on improving execution of the fundamentals and transforming the company by simplifying and standardizing our processes and footprint and reshaping the portfolio. Together, these actions will drive structurally higher growth and stronger margin performance, while improving enterprise resilience and predictability."

    Brown added, "We had a good start to the year, and despite operating in a volatile environment, we remain confident in achieving our 2026 guidance while staying committed to our long-term strategy - investing in growth, driving operational performance, and returning cash to shareholders."

    First-quarter highlights:











    Q1 2026



    Q1 2025









    GAAP EPS



    $      1.23



    $      2.04









    Special items:

















      Net costs (benefit) from significant litigation



    (0.04)



    0.41









      Loss on business divestitures



    0.01



    —









      Manufactured PFAS products



    0.18



    0.06









      (Increase) decrease in value of Solventum ownership



    0.67



    (0.63)









      Transformation costs



    0.09



    —









    Adjusted EPS



    $      2.14



    $      1.88



























    Memo:

















    GAAP operating income margin



    23.2 %



    20.9 %









    Adjusted operating income margin



    23.8 %



    23.5 %



    • GAAP EPS of $1.23 and operating margin of 23.2%.
    • Adjusted EPS of $2.14, up 14% year-on-year.
    • Adjusted operating income margin of 23.8%, an increase of 30 basis points year-on-year.










    GAAP



    Adjusted (non-GAAP)









    Net sales (billions)



    $6.0



    $6.0









    Sales change

















    Total sales



    1.3 %



    3.9 %









    Components of sales change:

















      Organic sales



    (1.4)



    1.2









      Acquisitions/divestitures



    (0.1)



    (0.1)









      Translation



    2.8



    2.8









    Adjusted sales excludes manufactured PFAS products.



    • Sales of $6.0 billion, up 1.3% year-on-year with organic sales down 1.4% year-on-year.
    • Adjusted sales of $6.0 billion, up 3.9% year-on-year with adjusted organic sales up 1.2% year-on-year.
    • 3M returned $2.4 billion to shareholders via dividends and share repurchases.
    • Cash from operations of $0.6 billion.
    • Adjusted free cash flow of $0.5 billion.

    Full-year 2026 guidance

    3M reiterated the following full-year 2026 expectations.

    • Adjusted total sales growth1 of ~4 percent, reflecting adjusted organic sales growth1 of ~3 percent.
    • Adjusted operating income margin expansion1 of 70 bps to 80 bps.
    • Adjusted EPS1 in the range of $8.50 to $8.70.
    • Adjusted operating cash flow1 of $5.6 to $5.8 billion, contributing to >100 percent adjusted free cash flow conversion1.

    1As further discussed at 4 within the "Supplemental Financial Information Non-GAAP Measures" sections, 3M cannot, without unreasonable effort, forecast certain items required to develop meaningful comparable GAAP financial measures and, therefore, does not provide them on a forward-looking basis reflecting these items.

    Conference call

    3M will conduct an investor teleconference at 9 a.m. ET (8 a.m. CT) today. Investors can access this conference via the following:

    • Live webcast at https://investors.3M.com 
    • Webcast replay at https://investors.3m.com/financials/quarterly-earnings 

    Consolidated financial statements and supplemental financial information non-GAAP measures

    View the Financial Statement Information on 3M's website: https://investors.3m.com/financials/quarterly-earnings

    Forward-looking statements

    Certain statements in this document, as well as other filings we make with the United States Securities and Exchange Commission ("SEC") and other written and oral information we release are considered "forward-looking statements" under the federal securities laws, including the Private Securities Litigation Reform Act of 1995, as amended (the "PSLRA"). Forward-looking statements may appear throughout this document and are typically identified by the words "aim," "anticipate," "believe," "can," "continue," "could," "estimate," "evaluate," "expect," "forecast," "future," "goal," "guidance," "impact," "initial," "intend," "likely," "may," "outlook," "plan," "possible," "potential," "predict," "probable," "project," "seek," "should," "strategy," "target," "will," "would," and other words that are similar to, or have the opposite meanings, of those words.

    All forward-looking statements are intended to enjoy the protection of the PSLRA's safe harbor for forward looking-statements, as well as the protections provided by other securities laws. Forward-looking statements speak only as of the date they are made and the Company assumes no obligation to update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on any of these forward-looking statements.

    Although the Company believes it has a reasonable basis for the forward-looking statements it makes, those statements are based on certain assumptions and expectations of future events and trends that are subject to risks and uncertainties. Changes in those assumptions, expectations, or other factors could produce materially different results. The most important risks, uncertainties, and other factors that could cause the Company's actual results to differ from the Company's forward-looking statements include:(1) worldwide economic, political, regulatory, international trade, geopolitical, tariffs, and retaliatory counter measures, capital markets, and other external conditions, (2) foreign currency exchange rates and fluctuations in those rates, (3) liabilities and contingencies related to PFAS, including liabilities related to claims, lawsuits, and government regulatory proceedings concerning various PFAS-related products and chemistries, as well as risks related to the Company's exit of PFAS manufacturing and work to discontinue use of PFAS across its product portfolio, (4) risks related to the PWS Settlement to resolve claims by public water suppliers in the United States regarding PFAS, as well as risks related to ongoing PFAS-related settlements and claims, (5) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's reports on Form 10-K, 10-Q, and 8-K, as well as compliance risks related to legal or regulatory requirements, government contract requirements, policies and practices, or other matters that require or encourage the Company or its customers, suppliers, vendors, or channel partners to conduct business in a certain way, (6) competitive conditions and customer preferences, (7) the timing and market acceptance of new product and service offerings, (8) the availability and cost of purchased components, compounds, raw materials and energy due to shortages, increased demand and wages, tariffs, supply chain interruptions, or natural or other disasters, (9) unanticipated problems or delays when implementing new business systems and solutions, including with the phased implementation of a global enterprise resource planning system, or security breaches and other disruptions to the Company's information or operational technology infrastructure, (10) use of artificial intelligence technologies, (11) the impact of acquisitions, strategic alliances, divestitures, and other strategic events resulting from portfolio management actions and other evolving business strategies, (12) operational execution, including the extent to which the Company can realize the benefits of planned productivity improvements, as well as the impact of organizational restructuring activities, (13) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans, (14) the Company's credit ratings and its cost of funding, (15) tax-related external conditions, including changes in tax rates, laws, or regulations, (16) matters relating to the Company's Aearo Entities, Combat Arms Earplugs Settlement, and related products, and (17) matters relating to the spin-off of Solventum, the Company's former Health Care business, into an independent public company.

    Those risks, uncertainties, and other factors are further described in Part I, Item 1A, "Risk Factors" of the Company's Form 10-K for the year ended December 31, 2025. For additional information concerning factors that may cause actual results to differ materially from the Company's forward-looking statements, see the Company's reports on Form 10-K, 10-Q, and 8-K filed with the SEC from time to time.

    About 3M

    3M (NYSE:MMM) is focused on transforming industries around the world by applying science and creating innovative, customer-focused solutions. Our multi-disciplinary team is working to solve tough customer problems by leveraging diverse technology platforms, differentiated capabilities, global footprint, and operational excellence. Discover how 3M is shaping the future at 3M.com/news.

    Please note that the company announces material financial, business and operational information using the 3M investor relations website, SEC filings, press releases, public conference calls and webcasts. The company also uses the 3M News Center and social media to communicate with our customers and the public about the company, products and services and other matters. It is possible that the information 3M posts on the News Center and social media could be deemed to be material information. Therefore, the company encourages investors, the media and others interested in 3M to review the information posted on 3M's News Center and the social media channels such as @3M or @3MNews.

    Contacts

    3M

    Investor Contact:

    Diane Farrow, 612-202-2449

    Media Contact:

    [email protected]

    3M (PRNewsfoto/3M)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/3m-reports-first-quarter-2026-results-302747982.html

    SOURCE 3M Company

    Get the next $MMM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MMM

    DatePrice TargetRatingAnalyst
    1/16/2026$182.00Overweight → Neutral
    Analyst
    12/8/2025$178.00Buy → Hold
    Deutsche Bank
    10/22/2025$160.00Underweight → Equal-Weight
    Morgan Stanley
    1/22/2025$140.00 → $170.00Equal Weight → Overweight
    Wells Fargo
    11/13/2024$184.00Neutral → Buy
    UBS
    10/22/2024Hold → Buy
    Melius
    9/6/2024$125.00Underweight
    Morgan Stanley
    7/30/2024$145.00Hold → Buy
    Argus
    More analyst ratings

    $MMM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    3M downgraded by Analyst with a new price target

    Analyst downgraded 3M from Overweight to Neutral and set a new price target of $182.00

    1/16/26 8:27:24 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded 3M from Buy to Hold and set a new price target of $178.00

    12/8/25 8:20:58 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded 3M from Underweight to Equal-Weight and set a new price target of $160.00

    10/22/25 6:59:04 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    January 22, 2021 - Coronavirus (COVID-19) Update: January 22, 2021

    For Immediate Release: January 22, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The FDA’s Office of Criminal Investigations recently investigated a case that has led to an arrest and the filing of a criminal complaint by the U.S. Department of Justice for introducing misbranded drugs into interstate commerce. The criminal investigation found th

    1/22/21 3:54:10 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Goralski Christian T Jr

    4 - 3M CO (0000066740) (Issuer)

    4/9/26 4:18:29 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Dickson Zoe L

    4 - 3M CO (0000066740) (Issuer)

    4/2/26 4:06:31 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Group President Gallagher Paul Joseph

    4 - 3M CO (0000066740) (Issuer)

    3/3/26 4:06:26 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    3M Reports First-Quarter 2026 Results

    Q1 GAAP sales of $6.0 billion, up 1.3%; operating margin of 23.2%, up 230 bps; EPS of $1.23, down 40%, all YoYAdjusted sales of $6.0 billion with organic growth of 1.2% YoYAdjusted operating margin of 23.8%, up 30 bps YoYAdjusted EPS of $2.14, up 14% YoYQ1 operating cash flow of $0.6 billion with adjusted free cash flow of $0.5 billionReiterates full-year 2026 guidanceST. PAUL, Minn., April 21, 2026 /PRNewswire/ -- 3M (NYSE:MMM) today reported first-quarter results."We are executing on 3M's value creation framework to build a stronger company," said William Brown, 3M Chairman and CEO. "Our focus remains on improving execution of the fundamentals and transforming the company by simplifying an

    4/21/26 6:30:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M Announces Upcoming Investor Event

    ST. PAUL, Minn., April 8, 2026 /PRNewswire/ -- 3M (NYSE:MMM) today announced the following investor event:First-quarter 2026 earnings conference call on Tuesday, April 21, 2026, at 8 a.m. CT.This event will be webcast live and a replay will be available on 3M's Investor Relations website at http://investors.3M.com.About 3M3M (NYSE:MMM) is focused on transforming industries around the world by applying science and creating innovative, customer-focused solutions. Our multi-disciplinary team is working to solve tough customer problems by leveraging diverse technology platforms, differentiated capabilities, global footprint, and operational excellence. Discover how 3M is shaping the future at 3M

    4/8/26 11:42:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M to create a leading fire and safety business; acquires Madison Fire & Rescue and combines with Scott Safety

    3M will form a new joint venture to offer best-in-class safety, fire-rescue, and suppression solutions for firefighters, first responders, and industrial workersST. PAUL, Minn., March 19, 2026 /PRNewswire/ -- 3M (NYSE: MMM) announced today that it has entered into a definitive agreement to acquire Madison Fire & Rescue, in partnership with Bain Capital. 3M and Bain Capital will establish a new joint venture in which 3M will contribute Scott Safety, receive $700M of cash proceeds upon closing and own 50.1% of the new company with Bain Capital owning 49.9%. 3M's deep expertise and track record in the safety industry combined with Bain Capital's capability to integrate businesses, accelerate gr

    3/19/26 6:45:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    SEC Filings

    View All

    SEC Form 10-Q filed by 3M Company

    10-Q - 3M CO (0000066740) (Filer)

    4/21/26 12:22:13 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M Company filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - 3M CO (0000066740) (Filer)

    4/21/26 6:34:26 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    SEC Form DEFA14A filed by 3M Company

    DEFA14A - 3M CO (0000066740) (Filer)

    3/27/26 7:44:52 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    Financials

    Live finance-specific insights

    View All

    3M Reports First-Quarter 2026 Results

    Q1 GAAP sales of $6.0 billion, up 1.3%; operating margin of 23.2%, up 230 bps; EPS of $1.23, down 40%, all YoYAdjusted sales of $6.0 billion with organic growth of 1.2% YoYAdjusted operating margin of 23.8%, up 30 bps YoYAdjusted EPS of $2.14, up 14% YoYQ1 operating cash flow of $0.6 billion with adjusted free cash flow of $0.5 billionReiterates full-year 2026 guidanceST. PAUL, Minn., April 21, 2026 /PRNewswire/ -- 3M (NYSE:MMM) today reported first-quarter results."We are executing on 3M's value creation framework to build a stronger company," said William Brown, 3M Chairman and CEO. "Our focus remains on improving execution of the fundamentals and transforming the company by simplifying an

    4/21/26 6:30:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M Announces Upcoming Investor Event

    ST. PAUL, Minn., April 8, 2026 /PRNewswire/ -- 3M (NYSE:MMM) today announced the following investor event:First-quarter 2026 earnings conference call on Tuesday, April 21, 2026, at 8 a.m. CT.This event will be webcast live and a replay will be available on 3M's Investor Relations website at http://investors.3M.com.About 3M3M (NYSE:MMM) is focused on transforming industries around the world by applying science and creating innovative, customer-focused solutions. Our multi-disciplinary team is working to solve tough customer problems by leveraging diverse technology platforms, differentiated capabilities, global footprint, and operational excellence. Discover how 3M is shaping the future at 3M

    4/8/26 11:42:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M to create a leading fire and safety business; acquires Madison Fire & Rescue and combines with Scott Safety

    3M will form a new joint venture to offer best-in-class safety, fire-rescue, and suppression solutions for firefighters, first responders, and industrial workersST. PAUL, Minn., March 19, 2026 /PRNewswire/ -- 3M (NYSE: MMM) announced today that it has entered into a definitive agreement to acquire Madison Fire & Rescue, in partnership with Bain Capital. 3M and Bain Capital will establish a new joint venture in which 3M will contribute Scott Safety, receive $700M of cash proceeds upon closing and own 50.1% of the new company with Bain Capital owning 49.9%. 3M's deep expertise and track record in the safety industry combined with Bain Capital's capability to integrate businesses, accelerate gr

    3/19/26 6:45:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    Leadership Updates

    Live Leadership Updates

    View All

    3M appoints Meagan Linn as Senior Vice President, Government Affairs

    ST. PAUL, Minn., Feb. 16, 2026 /PRNewswire/ -- 3M today announced the appointment of Meagan Linn as Senior Vice President, Government Affairs. In this role, Linn will oversee the company's engagement with the executive branch, policymakers, regulatory agencies, and industry associations, globally to advance public policy dialogue. She will also be responsible for developing business growth through government contracts. Linn brings 20 years of experience in public policy, with 12 years at Northrop Grumman Corporation, most recently as government policy lead and Chief of Staff, an

    2/16/26 10:00:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    Lanvin Group Announces Appointment of New Chief Financial Officer

    SHANGHAI, Oct. 24, 2025 /PRNewswire/ -- Lanvin Group (NYSE:LANV), a global luxury fashion group, today announced the appointment of Mr. Jiyang Han as Chief Financial Officer (CFO) of the Company, effective November 1, 2025. In this role, Mr. Han will oversee the Group's financial affairs, including financial planning and analysis, accounting and controllership, financial management, treasury, investment and financing projects, and investor relations.  Mr. Han brings nearly two decades of experience in corporate finance, investment banking, and global business management. He has served as Co-CIO and Assistant President of Yuyuan (SHSE: 600655) since June 2025. Prior to that, he was the M&A a

    10/24/25 6:00:00 AM ET
    $LANV
    $MMM
    Apparel
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care

    3M Annual Meeting Results

    ST. PAUL, Minn., May 13, 2025 /PRNewswire/ -- At today's Annual Meeting of Shareholders, 3M (NYSE:MMM) shareholders overwhelmingly supported each of the proposals recommended for approval by the company. Preliminary Shareholder Voting Results 3M shareholders today voted on the following business items: 1) Shareholders supported 11 directors for one-year terms to expire at the company's 2026 Annual Meeting: David P. Bozeman, President, Chief Executive Officer and Director, C.H. Robinson Worldwide, Inc.Thomas "Tony" K. Brown, retired Group Vice President, Global Purchasing, Ford

    5/13/25 4:30:00 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by 3M Company (Amendment)

    SC 13G/A - 3M CO (0000066740) (Subject)

    2/13/24 4:56:03 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by 3M Company (Amendment)

    SC 13G/A - 3M CO (0000066740) (Subject)

    2/9/23 10:54:46 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by 3M Company (Amendment)

    SC 13G/A - 3M CO (0000066740) (Subject)

    2/9/22 3:15:56 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care